Connect Biopharma Holdings Limited

NASDAQ: CNTB · Healthcare · Biotechnology

PublicHQ San Diego, CIK 0001835268Reports USD

#1065 of 1,402 Healthcare companies by revenuebottom-decile growth

EA Score

——

FH 28DQ —GM —SS 47

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, market scale · ↓ operating margin, net margin

Methodology →

Revenue TTM

$64.0k

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$55.5M

Employees

Market cap

$142.3M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$64.0k$64.0k2025

Net income-$55.5M-$55.5M2025

Operating income-$58.1M-$58.1M2025

Total assets$56.1M$56.1M2025

Liabilities$14.1M$14.1M2025

Equity$42.0M$42.0M2025

Revenue trend

FY2024 – FY2025 · USD

FY24

$26.0M

FY24

$64.0k

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Connect Biopharma Holdings Limited booked $64.0k in FY2025 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -86687.5% net margin.

Peers · Healthcare

Vor Biopharma Inc.——Organigram Global Inc.——Korro Bio, Inc.41D Agenus Inc.68B

Key facts

CEOBarry D. Quart

SectorHealthcare

IndustryBiotechnology

HeadquartersSan Diego, null

ExchangeNASDAQ: CNTB

Employees64

IPO date2021-03-19

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.